Search from website
Search from website
WHO WE ARE
Icosagen is Estonia’s largest biotechnology company and a leading
European CRDMO — Contract Research, Development, and Manufacturing Organization.
Icosagen is a research-driven contract research provider for biopharmaceutical and biotechnology industries that deftly adapts to market forces and current trends, and is always guided by the needs of its customers.
The Group comprises four entities: parent company Icosagen AS and three subsidiaries: Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and IcoPark OÜ.
OUR HISTORY
Founded in the late 1990s by a group of Estonian scientists, Icosagen began its journey under the name Quattromed. After a successful spin-off and sale of its diagnostics division in 2008, the company refocused its mission on biologics development. Today, Icosagen operates under the continued leadership of Professor Mart Ustav, whose deep expertise in virology and molecular biology has guided the development of proprietary protein expression systems and advanced manufacturing capabilities.
OUR CAPABILITIES
Icosagen provides a full spectrum of services across the biologics development lifecycle. From early therapeutic antibody discovery and cell line development to upstream and downstream process optimization, analytical testing, and clinical GMP manufacturing — we deliver everything in-house. This one-site, one-team, one-project model ensures full traceability, reduced handovers, and consistent quality throughout each phase of development.
OUR FACILITIES
Our integrated campus in Tartu, Estonia, houses R&D laboratories, bioprocessing suites, and a newly built GMP manufacturing facility. Equipped with cutting-edge technologies and a fully digital QA documentation system, our facility enables flexible and compliant production at scales up to 1000 L. This infrastructure allows us to meet rigorous regulatory and quality standards.
OUR TEAM
Icosagen employs over 230 highly skilled scientists, engineers, and technical professionals. Our multidisciplinary team brings deep expertise in molecular biology, protein engineering, cell line development, bioprocessing, and manufacturing. Whether developing early-stage candidates or supporting clinical submissions, we work in close collaboration with our clients to ensure scientific rigor, transparency, and success at every milestone.
RECOGNITION & AWARDS
Icosagen has been nominated for Company of the Year and Innovator of the Year at Estonia’s prestigious Annual Enterprise Awards. These recognitions reflect our contributions to advancing the biotechnology sector and our leadership in bringing innovative biologics solutions to market.
For our customers, we provide opportunities and contributions to make their activities simpler, more efficient and less risky.
Internally, we continuously develop and improve our products, technologies and services to provide additional innovation and benefit to our customers. Our company has over 140 skilled and committed professional team members. The management system complies with the requirements of the ISO 9001:2015 standard.
We are a leading biotechnology group in Estonia having provided custom-tailored services as well as catalogue products for global customers in academia, pharma, biotech and industry for several years.
© 2026 Icosagen
